Myeloma UK Publication, intended for UK Audience: Myeloma – An Introduction - Myeloma Essentials
Myeloma UK Publication, intended for UK Audience Myeloma – An Introduction - Myeloma Essentials https://www.myeloma.org.uk/...
Dec 1, 2023
NCCN GUIDELINES FOR PATIENTS: MULTIPLE MYELOMA 2023
NCCN GUIDELINES FOR PATIENTS: MULTIPLE MYELOMA 2023 Click here to see patient's guideline book by NCCN. Presented with support from: NCCN...
Dec 1, 2023
What is Multiple Myeloma? www.uptodate.com
www.uptodate.com - What is Multiple Myeloma? Patient education: Multiple myeloma symptoms, diagnosis, and staging (Beyond the Basics)...
Dec 1, 2023
Patient Education: Daratumumab & Daratumumab and Hyaluronidase-fihj - Monoclonal Ab - Immunotherapy
Patient Education: Daratumumab & Daratumumab and Hyaluronidase-fihj DARATUMUMAB (DARZALEX) NIH National cancer institute - cancer.gov...
Dec 16, 2022
Patient Education: Lenalidomide - Immunomodulatory Agents - IMIDS
Patient Education: Revlimid (lenalidomide) - Immunomodulatory Agents - IMIDS LENALIDOMIDE (REVLIMID) NIH National cancer institute...
Dec 15, 2022
Patient Education: Bortezomib (Velcade) - Proteasome Inhibitor
Patient Education: Bortezomib (Velcade) - Proteasome Inhibitors BORTEZOMIB (VELCADE) NIH National cancer institute -cancer.gov site info...
Dec 10, 2022
Patient Education: Carfilzomib (Kyprolis) - Proteasome Inhibitor
Patient Education: Carfilzomib (Kyprolis) - Proteasome Inhibitor Carfilzomib NIH National cancer institute - cancer.gov site info This...
Dec 9, 2022
Patient Education: Ciltacabtagene Autoleucel - Carvykti - (CART Cell Therapy) - Immunotherapy
Patient Education: Ciltacabtagene Autoleucel https://www.carvykti.com Ciltacabtagene Autoleucel ( Carvykti) FDA approves ciltacabtagene...
Dec 6, 2022
Patient Education: Idecabtagene Vicleucel (CART Cell Therapy) - Immunotherapy
Patient Education: Idecabtagene Vicleucel ABECMA (idecabtagene vicleucel) is a B-cell maturation antigen (BCMA)-directed genetically...
Dec 6, 2022
Patient Education: Isatuximab-irfc - Sarclisa - Monoclonal Antibody - Immunotherapy
Patient Education: Isatuximab-irfc - Sarclisa - Monoclonal Antibody - Immunotherapy ISATUXIMAB-IRFC (SARCLISA) NIH National cancer...
Dec 6, 2022
Patient Education: Pomalidomide (Pomalyst) Immunomodulatory Agents - IMIDS
Patient Education: Pomalidomide (Pomalyst) Immunomodulatory Agents - IMIDS POMALIDOMIDE (POMALYST) NIH National cancer institute -...
Dec 5, 2022
Patient Education: Elotuzumab (Empliciti) - Anti-SLAMF7 Monoclonal Antibody - Immunotherapy
Patient Education: Elotuzumab (Empliciti) - Anti-SLAMF7 Monoclonal Antibody - Immunotherapy ELOTUZUMAB (EMPLICITI) NIH National cancer...
Dec 4, 2022
Patient Education: Thalidomide (Thalomid) Immunomodulatory Agents - IMIDS
Patient Education: Thalidomide (Thalomid) Immunomodulatory Agents - IMIDS THALIDOMIDE NIH National cancer institute - cancer.gov site...
Dec 4, 2022
Why is it important to become your own best advocate? HealthTree University Myeloma
Why is it important to become your own best advocate? Why is it important to become your own best myeloma advocate? HealthTree University...
Dec 3, 2022
What is a Myeloma Specialist Why do I Need one and How do I Find One? HealthTree University Myeloma
What is a Myeloma Specialist, Why do I Need one, and How do I Find One? HealthTree University Myeloma Dec 13, 2019 Learn more: HealthTree...
Dec 3, 2022
Patient Education: Ixazomib (Ninlaro) - Proteasome Inhibitor
Patient Education: Ixazomib (Ninlaro) - Proteasome Inhibitor IXAZOMIB (NINLARO) NIH National cancer institute - cancer.gov site info This...
Dec 3, 2022
Patient Education: Selinexor (Xpovio) - XPO1 inhibitor
Patient Education: Selinexor (Xpovio) - XPO1 inhibitor Selinexor (Xpovio) NIH National cancer institute - cancer.gov site info This page...
Dec 2, 2022
Patient Education: Dexamethasaone (Decadron) and other Steroids
Patient Education: Dexamethasone and other steroids DEXAMETHASONE (DECADRON) NIH National cancer institute -cancer.gov site info on...
Dec 1, 2022
Patient Education: Belantamab Mafodotin-blmf (Blenrep) Antibody Drug Conjugate for Multiple Myeloma
Patient Education: Belantamab Mafodotin-blmf * Belantamab mafodotin (Withdrawn from United States market) Belantamab Mafodotin-blmf...
Dec 1, 2022